Originalkatalog | Verfügbarkeit prüfen

Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands

van Haalen, H.G.M., Pompen, M., Bergenheim, K., McEwan, P., Townsend, R., Roudaut, M.
Veröffentlicht in: Value in Health ; volume 16, issue 7, page A441 ; ISSN 1098-3015;
2013